Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial. (2022). SKIN The Journal of Cutaneous Medicine, 6(2), s29. https://doi.org/10.25251/skin.6.supp.s29